Wellesley Pharmaceuticals, LLC was founded to ensure that the ability of Nocturolto reduce and sometimes eliminate Nocturia symptoms can be disseminated to help the hundreds of millions of people who can benefit from it.

Nocturol’s ability to reduce bathroom visits is now supported by 9 issued US method-of-use patents that have been granted.  Patent protection around the world is underway with patents already having been granted in Australia, New Zealand, Russia, Singapore, South Africa, and Taiwan.